Sprint bioscience market cap

Sprint Bioscience AB advanced stock charts by MarketWatch. View SPRINT historial stock data and compare to other stocks and exchanges.

Sprint Bioscience AB advanced stock charts by MarketWatch. View SPRINT historial stock data and compare to other stocks and exchanges. Sprint Bioscience has 30 employees at their 1 location. See insights on Sprint Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Market capitalization (28-Jan-2021) 162.9m: Closing stock price (28-Jan-2021) 7.7: SPRINT:STO price falls below 15-day moving average to 7.24 at 14:48 GMT Feb 16 2021 Key statistics On Thursday, Sprint Bioscience AB (SPRINT:STO) closed at 6.52, 36.76% above the 52 week low of 4.77 set on Mar 16, 2020. May 17, 2019 Sprint fundamental comparison: Net Income vs Market Capitalization. For Sprint profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sprint to generate income relative to revenue, assets, operating costs, and current equity.

30.01.2021

Last Updated. 2021/01/16 18:51 UTC. Data Sources. Company Financials + 1 Analyst. Market.

Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug

6.98SEK. Market Closed.

Nordic Large Cap; Nordic Mid Cap; Nordic Small Cap Nordic Small Cap; Norwegian Listed Shares . COMPANIES LISTED ON NASDAQ FIRST NORTH PREMIER Growth Market. Companies below are listed on Nasdaq First North Premier Growth Market. For viewing other markets or segments, please use the links in the right column. Sprint Bioscience: SPRINT

The biotechnology company earns $-14,260,000.00 in net income (profit) each year or ($0.97) on an Feb 25, 2021 · (NASDAQ: SPRB) Spruce Biosciences's market cap is $456.32M, as of Feb 25, 2021.

Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company.

Sprint Find the latest Sprint Bioscience AB (SPRINT.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company. s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to SPRINT, Sprint Bioscience, (SE0006343745) Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market.

Sprint Bioscience AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other companies in this sector in SWEDEN : Intervacc AB (2019 sales of 12.14 million Swedish Kronor [US$1.49 million] ), SyntheticMR AB (publ) (45.80 million Swedish Kronor [US$5.61 million Latest Sprint Bioscience AB Share Price - Live SPRINT TO1 share price quotes, charts, profile, RNS & company financials for STO:SPRINT TO1 Micro Cap Style Market Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis. SPRINT, Sprint Bioscience, (SE0006343745) Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Market Cap. 159.54M. Dividend Rate (Yield) - (0.00%) Beta.

View SPRINT historial stock data and compare to other stocks and exchanges. Sprint Bioscience has 30 employees at their 1 location. See insights on Sprint Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Market capitalization (28-Jan-2021) 162.9m: Closing stock price (28-Jan-2021) 7.7: SPRINT:STO price falls below 15-day moving average to 7.24 at 14:48 GMT Feb 16 2021 Key statistics On Thursday, Sprint Bioscience AB (SPRINT:STO) closed at 6.52, 36.76% above the 52 week low of 4.77 set on Mar 16, 2020. May 17, 2019 Sprint fundamental comparison: Net Income vs Market Capitalization. For Sprint profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sprint to generate income relative to revenue, assets, operating costs, and current equity. Get Sprint Bioscience AB (SPRINT-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC.

1.45. Shares Outstanding. 21.21M. P/E Ratio (EPS)-Recent News. Sprint Bioscience AB SPRINT Morningstar%2c Inc. 11/25/2020. Sprint Stock analysis for Sprint Bioscience AB (5JA1:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer.

ma velké písmeno
národní identifikační karta.com.bd
co je gnostická víra
predikce ceny bitcoinů na redditu 2021
ať žije král meme šablony

View the latest Sprint Bioscience AB (SPRINT) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying

Market Cap … Feb 19, 2021 Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company. s strategy involves out-licensing or collaborating … Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year. Latest Sprint Bioscience AB Share Price - Live SPRINT TO1 share price quotes, charts, profile, RNS & company financials for STO:SPRINT TO1 Micro Cap Style Market Cap: £15.0m: Enterprise Value: £11.8m: Revenue: £1.85m Sep 28, 2009 Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development.